J. Michiels

发表

The Place of D-Dimer Testing in an Integrated Approach of Patients Suspected of Pulmonary Embolism

P. de Moerloose, H. Bounameaux, J. Michiels, 1998, Seminars in thrombosis and hemostasis.

Does pre-treatment with aspirin and loading dose clopidogrel obviate the need for glycoprotein IIb/IIIa antagonists during elective coronary stenting? A focus on peri-procedural myonecrosis.

F. Wuyts, M. Claeys, J. Bosmans, 2005, European heart journal.

Exclusion of deep vein thrombosis with rapid ELISA D-dimer testing: from theory to daily practice.

M. Janssen, P. de Moerloose, F. van der Graaf, 1999, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Should a normal D-dimer rule out angiographic pulmonary embolism or unfavorable outcome in patients left untreated?

H. Bounameaux, A. Perrier, J. Michiels, 2001, Thrombosis and haemostasis.

The reduction of large von Willebrand factor multimers in plasma in essential thrombocythaemia is related to the platelet count

P. V. van Genderen, R. van Strik, U. Budde, 1996, British journal of haematology.

Aspirin and Platelet-Lowering Agents for the Prevention of Vascular Complications in Essential Thrombocythemia

J. Michiels, J. Michiels, 1999, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Prevention and treatment of thrombotic complications in essential thrombocythaemia: efficacy and safety of aspirin

P. V. van Genderen, M. Waleboer, P. Mulder, 1997, British journal of haematology.

Transient neurological and ocular manifestations of primary thrombocythemia

P. Koudstaal, P. Koudstaal, J. Michiels, 1993 .

Comparison of antiplatelet effect of loading dose of clopidogrel versus abciximab during coronary intervention

M. Claeys, J. Bosmans, C. Vrints, 2002, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Comparison of turbidimetric aggregation and in vitro bleeding time (PFA-100) for monitoring the platelet inhibitory profile of antiplatelet agents in patients undergoing stent implantation.

Z. Berneman, M. Claeys, J. Bosmans, 2003, Thrombosis research.

Acquired Hemophilia A in Women Postpartum: Clinical Manifestations, Diagnosis, and Treatment

J. Michiels, J. Michiels, 2000, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Spontaneous Erythroid Colony Formation as the Clue to an Underlying Myeloproliferative Disorder in Patients with Budd-Chiari Syndrome or Portal Vein Thrombosis

G. Leone, V. De Stefano, L. Teofili, 1997, Seminars in thrombosis and hemostasis.

Laboratory Diagnosis of Hereditary Thrombophilia

K. Hamulyák, J. Michiels, K. Hamulyak, 1998, Seminars in thrombosis and hemostasis.

Aspirin resistance: does it exist?

G. Rao, J. Michiels, 2007, Seminars in thrombosis and hemostasis.

Normal Life Expectancy and Thrombosis-Free Survival in Aspirin Treated Essential Thrombocythemia

J. Michiels, J. Michiels, 1999, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Symposium in memory of Professor Inga Marie Nilsson

M. Blombäck, P. Mannucci, J. Astermark, 2001 .

Acquired haemophilia A in women postpartum: management of bleeding episodes and natural history of the factor VIII inhibitor

H. Nieuwenhuis, I. Novàkovà, K. Hamulyák, 1997, European journal of haematology.

A healthy hemophilic patient without arthropathy: from concept to clinical reality.

E. Berntorp, J. Michiels, 2003, Seminars in thrombosis and hemostasis.

Distal deep venous thrombosis in a hemophilia A patient with inhibitor and severe infectious disease, 18 days after recombinant activated factor VII transfusion.

Z. Berneman, W. Schroyens, M. G. Van der Planken, 2002, Blood Coagulation and Fibrinolysis.

Hereditary Protein S Deficiency and Venous Thrombo-Embolism

E. Briët, R. Bertina, J. Leeuw, 1985, Thrombosis and Haemostasis.

Essential Thrombocythemia in Childhood

P. V. van Genderen, J. Michiels, J. Michiels, 1997, Seminars in thrombosis and hemostasis.

Thromboxane‐dependent platelet activation in vivo precedes arterial thrombosis in thrombocythaemia: a rationale for the use of low‐dose aspirin as an antithrombotic agent

P. V. van Genderen, K. Schrör, J. Michiels, 1999, British journal of haematology.

Erythromelalgia in Essential Thrombocythemia Is Characterized by Platelet Activation and Endothelial Cell Damage but not by Thrombin Generation

P. V. van Genderen, R. van Strik, V. Vuzevski, 1996, Thrombosis and Haemostasis.

High-dose Intravenous Immunoglobulin Delays Clearance of von Willebrand Factor in Acquired von Willebrand Disease

P. V. van Genderen, J. Michiels, W. Terpstra, 1995, Thrombosis and Haemostasis.

Acquired thrombophilia in pregnancy: essential thrombocythemia.

M. Griesshammer, J. Michiels, M. Grünewald, 2003, Seminars in thrombosis and hemostasis.

Platelet Consumption in Thrombocythemia Complicated by Erythromelalgia: Reversal by Aspirin

P. V. van Genderen, J. Lindemans, R. van Strik, 1995, Thrombosis and Haemostasis.

The Routine Determination of the Endogenous Thrombin Potential, First Results in Different Forms of Hyper- and Hypocoagulability

V. Kakkar, H. Hemker, S. Béguin, 1997, Thrombosis and Haemostasis.

Erythromelalgia and Thrombocythemia: A Disease of Platelet Prostaglandin Metabolism-Thesis, Rotterdam, 1981

J. Michiels, 1997, Seminars in thrombosis and hemostasis.

Homozygosity for a Novel Missense Mutation in the Prothrombin Gene Causing a Severe Bleeding Disorder

P. Reitsma, R. Bertina, S. Poort, 1994, Thrombosis and Haemostasis.

Erythromelalgia and Vascular Complications in Polycythemia Vera

J. Michiels, J. Michiels, 1997, Seminars in thrombosis and hemostasis.

The Paradox of Bleeding and Thrombosis in Thrombocythemia: Is von Willebrand Factor the Link?

P. V. van Genderen, J. Michiels, J. Michiels, 1997, Seminars in thrombosis and hemostasis.

Aspirin in Essential Thrombocythemia: Status Quo and Quo Vadis

M. Bangerter, M. Griesshammer, J. Michiels, 1997, Seminars in thrombosis and hemostasis.

Lipoxygenase Deficiency in Primary Thrombocythemia Is not a True Deficiency

F. Zijlstra, J. Michiels, P. Genderen, 1994, Thrombosis and Haemostasis.